| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +50.00% | +3.05% | -0.09% | +3.13% | -1.70% | — |
| 14d | 4 | +75.00% | +1.32% | +0.49% | +0.83% | -4.68% | — |
| 30d | 4 | +75.00% | -13.45% | +1.56% | -15.01% | -10.57% | — |
| 60d | 4 | +50.00% | -11.92% | +3.68% | -15.60% | -11.66% | — |
| 90d | 4 | +50.00% | -13.16% | +7.14% | -20.31% | -19.69% | — |
| 180d | 4 | +75.00% | -33.39% | +7.38% | -40.77% | -37.45% | — |
| 1y | 4 | +75.00% | -31.00% | +16.55% | -47.55% | -45.66% | — |
| 2y | 4(2 pending) | +100.00% | -81.05% | +26.66% | -107.72% | -107.72% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| PMVP PMV PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 303,310 | — | — | 303,310 | Mar 5, 2026 | Mar 9, 2026 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | SALE Chief Development Officer | 33,065 | $1.06 | $35.2K | 89,959 | Jul 1, 2025 | Jul 3, 2025 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 300,000 | — | — | 300,000 | Mar 3, 2025 | Mar 5, 2025 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | SALE Chief Development Officer | 7,218 | $1.50 | $10.9K | 118,283 | Sep 11, 2024 | Sep 12, 2024 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | SALE Chief Development Officer | 125,000 | — | — | 0 | Aug 13, 2024 | Oct 3, 2024 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 125,000 | — | — | 125,000 | Aug 13, 2024 | Oct 3, 2024 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | SALE Chief Development Officer | 22,674 | — | — | 0 | Aug 13, 2024 | Oct 3, 2024 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | SALE Chief Development Officer | 68,100 | — | — | 0 | Aug 13, 2024 | Oct 3, 2024 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 90,774 | — | — | 90,774 | Aug 13, 2024 | Oct 3, 2024 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 225,095 | — | — | 225,095 | Jan 18, 2024 | Jan 22, 2024 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 95,555 | — | — | 125,501 | Jan 18, 2024 | Jan 22, 2024 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | SALE Chief Development Officer | 4,104 | $6.62 | $27.2K | 29,946 | Sep 15, 2023 | Sep 18, 2023 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 125,000 | — | — | 125,000 | May 12, 2023 | May 15, 2023 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 34,050 | — | — | 34,050 | Sep 9, 2022 | Sep 13, 2022 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 68,100 | — | — | 68,100 | Feb 10, 2022 | Feb 28, 2022 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | SALE SVP, Regulatory Affairs and QA | 2,896 | $33.78 | $97.8K | 0 | Aug 17, 2021 | Aug 18, 2021 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | SALE SVP, Regulatory Affairs and QA | 2,896 | — | — | 87,320 | Aug 17, 2021 | Aug 18, 2021 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | PURCHASE SVP, Regulatory Affairs and QA | 2,896 | $3.53 | $10.2K | 2,896 | Aug 17, 2021 | Aug 18, 2021 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 22,674 | — | — | 22,674 | May 12, 2021 | Jun 8, 2021 ↗ | View → |